PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving Chemotherapy

NCT02805166 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

420

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Solid Tumors

Interventions

DRUG: PEG-rhG-CSF

Sponsor

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.